The interaction of 6-mercaptopurine (6-MP) and methotrexate (MTX)

被引：35
作者：
Giverhaug, T [1 ]
Loennechen, T
Aarbakke, J
机构：
[1] Univ Tromso, Inst Pharm, Dept Pharmacol, N-9037 Tromso, Norway
[2] Univ Tromso, Inst Med Biol, N-9037 Tromso, Norway
来源：
GENERAL PHARMACOLOGY | 1999年 / 33卷 / 04期
关键词：
6-mercaptopurine; methotrexate; interaction;
D O I：
10.1016/S0306-3623(99)00022-1
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
The antimetabolites 6-mercaptopurine (6-MP) and metliotrexate (MTX) are the cornerstones in the maintenance treatment of children's acute lymphoblastic leukemia (ALL). The biochemical mechanisms underlying the increased therapeutic efficacy of the combination of these drugs have not yet been elucidated. However, both drugs interact with important pathways, such as purine de novo synthesis (PDNS), purine salvage, and methylation reactions. A review of the mechanistic aspects of the interactions between 6-MP and MTX is given. (C) 1999 Elsevier Science Inc. All rights reserved.
引用
收藏
页码：341 / 346
页数：6
相关论文
共 50 条
  • [41] Characterization of 6-mercaptopurine monolayers on Hg surfaces
    Sevilla, JM
    Pineda, T
    Madueno, R
    Roman, AJ
    Blazquez, M
    JOURNAL OF ELECTROANALYTICAL CHEMISTRY, 1998, 442 (1-2): : 107 - 112
  • [42] CHEMILUMINESCENT DETERMINATION OF 6-MERCAPTOPURINE IN PHARMACEUTICAL PREPARATION
    HE, ZK
    LIU, XL
    LUO, QY
    YU, XM
    ZENG, YE
    ANALYTICAL SCIENCES, 1995, 11 (03) : 415 - 417
  • [43] Summary of the workshop on 6-mercaptopurine/azathioprine pharmacology
    Markowitz, JF
    INFLAMMATORY BOWEL DISEASES, 1998, 4 (02) : 117 - 120
  • [44] Effects on transmethylation by high-dose 6-mercaptopurine and methotrexate infusions during consolidation treatment of acute lymphoblastic leukemia
    KeuzenkampJansen, CW
    DeAbreu, RA
    Blom, HJ
    Bokkerink, JPM
    Trijbels, JMF
    BIOCHEMICAL PHARMACOLOGY, 1996, 51 (09) : 1165 - 1171
  • [45] Role of base-excision repair in the treatment of childhood acute lymphoblastic leukaemia with 6-mercaptopurine and high doses of methotrexate
    Stanczyk, M.
    Sliwinski, T.
    Trelinska, J.
    Cuchra, M.
    Markiewicz, L.
    Dziki, L.
    Bieniek, A.
    Bielecka-Kowalska, A.
    Kowalski, M.
    Pastorczak, A.
    Szemraj, J.
    Mlynarski, W.
    Majsterek, I.
    MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS, 2012, 741 (1-2) : 13 - 21
  • [46] Impact of morning versus evening schedule for oral methotrexate and 6-mercaptopurine on relapse risk for children with acute lymphoblastic leukemia
    Schmiegelow, K
    Glomstein, A
    Kristinsson, J
    Salmi, T
    Schroder, H
    Bjork, O
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 1997, 19 (02) : 102 - 109
  • [47] PROGNOSTIC-SIGNIFICANCE OF METHOTREXATE AND 6-MERCAPTOPURINE DOSAGE DURING MAINTENANCE CHEMOTHERAPY FOR CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA
    SCHMIEGELOW, K
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 1991, 8 (04) : 301 - 312
  • [48] The effect of 6-mercaptopurine on early human placental explants
    Matalon, ST
    Ornoy, A
    Fishman, A
    Drucker, L
    Lishner, M
    HUMAN REPRODUCTION, 2005, 20 (05) : 1390 - 1397
  • [49] Acute Pancreatitis Secondary to 6-Mercaptopurine: a Case Report
    Eddoukani, I.
    Oubaha, S.
    Samlani, Z.
    Krati, K.
    JOURNAL AFRICAIN D HEPATO-GASTROENTEROLOGIE, 2016, 10 (04): : 220 - 222
  • [50] Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis
    Timmer, Antje
    Patton, Petrease H.
    Chande, Nilesh
    McDonald, John W. D.
    MacDonald, John K.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2016, (05):
12345